2
Total investments
1
Early stage
0
Mid stage
0
Late stage
11y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2015
2-BBB is developing medicines for the treatment of devastating brain diseases. Our proprietary liposomal G-Technology® facilitates entry to the brain while simultaneously enabling sustained delivery of systemically administered therapeutics. Our technology has been shown to be compatible with approved as well as novel therapeutic entities. We have two clinical programs, one targeting multiple indications of brain cancers and the other neuro-inflammatory diseases.
Experience · 5 entries
All (5)
Investments (2)
Founder (1)
Board (2)
2017
E
EnhanX Biopharm
Board Observer
Oct 2017
2015
Board Member
Apr 2015
2-BBB is developing medicines for the treatment of devastating brain diseases. Our proprietary liposomal G-Technology® facilitates entry to the brain while simultaneously enabling sustained delivery of systemically administered therapeutics. Our technology has been shown to be compatible with approved as well as novel therapeutic entities. We have two clinical programs, one targeting multiple indications of brain cancers and the other neuro-inflammatory diseases.
1996
N
NeBIB
Partner
1996
1995
S
Self-employed
Founder and Only Employee
Sep 1995
1992
R
RenderStar Technology
Managing Director
Sep 1992
Investor lists
Lists that match Philip Jan's portfolio
- Angel investors in the Netherlands1,052 investors
- Early-stage startup investors in Netherlands803 investors